|
⚲
|
| Keyboard |
| HEP Management Corporation
✚
|
|
|---|---|
| CRD # | 161855 |
| SEC # | 801-78087 |
| CIK # | 0001618035 |
| AUM | 426.6 M (2026-03-31) |
| Employees | 9 (89% Investors, 0% Brokers) |
| Phone | 646-217-4515 |
| Address | 565 Fifth Avenue New York, NY 10017-2470 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Health Enterprise Partners IV LP | [2022-03-25] | 236.3 M | |
| Offered $250,000,000 · Filed 2021-12-02 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $250,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Health Enterprise Partners III LP | [2018-03-28] | 177.5 M | 153.3 M |
| Offered $177,500,000 · Filed 2018-07-11 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Health Enterprise Partners II LP | [2012-10-09] | 136.4 M | 37.0 M |
| Offered $136,400,000 · Filed 2014-07-08 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Health Enterprise Partners LP | 2012-02-27 | 1.1 M | |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 426.6 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 426.6 |
| By Discretionary | ||
| Discretionary | 3 | 426.6 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 426.6 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 426.6 | |
| Total | 3 | 426.6 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Robert Schulz | Executive Officer | 15 | 3 | |
| Daniel Cain | Executive Officer | 5 | 3 | |
| David Tamburri | Executive Officer | 38 | 2 | |
| Ezra Mehlman | Executive Officer | 11 | 2 | |
| Richard Stowe | Executive Officer | 11 | 2 | |
| Peter Tedesco | Executive Officer | 3 | 2 | |
| Hep Associates IV LLC | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001618035] | |
| 4 | [0001618035] | |
| SC 13D | [0001618035] | |
| SC 13G | [0001618035] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| HEP Investments LLC | ZIVO Bioscience Inc | [2018-04-25] |
| HEP Investments LLC | ZIVO Bioscience Inc | [2015-05-01] |
| HEP Investments LLC | Health Enhancement Products Inc | [2014-09-04] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| HEP Investments LLC | |
| Health Enhancement Products Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Health Enhancement Products Inc ZIVO
Common Stock
|
2016-04-29 | Buy | 107,064 | $0.08 | 8,565 |
|
Health Enhancement Products Inc ZIVO
Accrued Interest converting into Common Stock · derivative
|
2016-04-15 | Buy | 5,902,729 | ||
|
Health Enhancement Products Inc ZIVO
Convertible Debt · derivative
|
2016-03-01 | Buy | 2,500,000 | $250,000.00 | 625,000,000,000 |
|
Health Enhancement Products Inc ZIVO
Common Stock Purchase Warrant · derivative
|
2016-03-01 | Buy | 250,000 | ||
|
Health Enhancement Products Inc ZIVO
Convertible Debt · derivative
|
2016-01-27 | Buy | 2,500,000 | $250,000.00 | 625,000,000,000 |
|
Health Enhancement Products Inc ZIVO
Common Stock Purchase Warrant · derivative
|
2016-01-27 | Buy | 250,000 | ||
|
Health Enhancement Products Inc ZIVO
Convertible Debt · derivative
|
2015-10-29 | Buy | 2,500,000 | $250,000.00 | 625,000,000,000 |
|
Health Enhancement Products Inc ZIVO
Common Stock Purchase Warrant · derivative
|
2015-10-29 | Buy | 250,000 | ||
|
Health Enhancement Products Inc ZIVO
Convertible Debt · derivative
|
2015-10-08 | Buy | 2,500,000 | $250,000.00 | 625,000,000,000 |
|
Health Enhancement Products Inc ZIVO
Common Stock Purchase Warrant · derivative
|
2015-10-08 | Buy | 250,000 | ||
|
Health Enhancement Products Inc ZIVO
Convertible Debt · derivative
|
2015-09-24 | Disposed to issuer | 250,000 | $30,000.00 | 7,500,000,000 |
|
Health Enhancement Products Inc ZIVO
Convertible Debt · derivative
|
2015-09-02 | Buy | 2,500,000 | $250,000.00 | 625,000,000,000 |
|
Health Enhancement Products Inc ZIVO
Common Stock Purchase Warrant · derivative
|
2015-09-02 | Buy | 250,000 | ||
|
Health Enhancement Products Inc ZIVO
Common Stock Purchase Warrant · derivative
|
2015-07-07 | Buy | 250,000 | ||
|
Health Enhancement Products Inc ZIVO
Convertible Debt · derivative
|
2015-07-07 | Buy | 2,500,000 | $250,000.00 | 625,000,000,000 |
|
Health Enhancement Products Inc ZIVO
Convertible Debt · derivative
|
2015-06-26 | Buy | 2,500,000 | $250,000.00 | 625,000,000,000 |
|
Health Enhancement Products Inc ZIVO
Common Stock Purchase Warrant · derivative
|
2015-06-26 | Buy | 250,000 | ||
|
Health Enhancement Products Inc ZIVO
Convertible Debt · derivative
|
2015-06-05 | Disposed to issuer | 250,000 | $30,000.00 | 7,500,000,000 |
|
Health Enhancement Products Inc ZIVO
Convertible Debt · derivative
|
2015-05-01 | Buy | 2,372,200 | $237,200.00 | 562,685,840,000 |
|
Health Enhancement Products Inc ZIVO
Common Stock Purchase Warrant · derivative
|
2015-05-01 | Buy | 237,200 | ||
| showing 20 of 34 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Faction Ventures LLC
✚
|
CA | 432.6 M |
|
Cotulla Holdings LLC
✚
|
432.5 M | |
|
Republic Capital Adviser LLC
✚
|
NY | 430.9 M |
|
CRUX Capital Ltd
✚
|
TX | 427.6 M |
|
Care Equity Capital Management LP
✚
|
426.9 M | |
|
Blue Like an Orange Capital US LLC
✚
|
DC | 426.5 M |
|
Dubin Clark & Company Inc
✚
|
FL | 425.2 M |
|
Forward Consumer Partners LLC
✚
|
CT | 425.0 M |
|
Spring Lane Management LLC
✚
|
MA | 424.7 M |
|
Zarvona Energy LLC
✚
|
TX | 423.1 M |